Abstract | BACKGROUND: Adverse left ventricular (LV) remodelling following acute ST-segment elevation myocardial infarction ( STEMI) has prognostic importance. We aimed to predict 90-day left ventricular (LV) function following acute STEMI using variables from clinical presentation, biomarkers, and cardiovascular magnetic resonance imaging (CMR). METHODS: RESULTS: Ninety-six patients were enrolled in the CMR sub study and 85 completed the 90-day follow-up, across 24 centres worldwide. LV ejection fraction (EF) was 56% (46-63%) at baseline and 60% (49-67%) at 90 days (p<0.001). Infarct size had moderate inverse correlation with 90-day EF (Spearman's rho=-0.7, p < 0.001) and had the strongest correlation when compared to myocardial salvage index (Spearman's rho=0.5, p=0.001), infarct heterogeneity (Spearman's rho=-0.4, p=0.02 or microvascular obstruction (Spearman's rho=-0.4, p<0.001). All biochemical markers had similar moderate relationship to LVEF at 90 days (Spearman's rho -0.6 to -0.8, p=0.001). In a multivariable model, only baseline LVEF, CMR infarct size and infarct heterogeneity independently predicted 90-day LVEF. CONCLUSION: This study reports findings of a combined CMR protocol (including myocardial oedema imaging) in a multi-centre, multi-vendor setting. We found infarct size, infarct heterogeneity and myocardial salvage index correlated favourably with 90-day LVEF, however only the former two were independently predictive.
|
Authors | Suchi Grover, Gregory Bell, Michael Lincoff, Lucas Jeorg, Per Lav Madsen, Saling Huang, Sean Leow, Gemma Figtree, Adhiraj Chakrabarty, Darryl P Leong, Richard J Woodman, Joseph B Selvanayagam |
Journal | Heart, lung & circulation
(Heart Lung Circ)
Vol. 24
Issue 9
Pg. 891-7
(Sep 2015)
ISSN: 1444-2892 [Electronic] Australia |
PMID | 25846255
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved. |
Chemical References |
|
Topics |
- Aged
- Biomarkers
(blood)
- Female
- Humans
- Male
- Middle Aged
- Myocardial Infarction
(blood, physiopathology, therapy)
- Myocardium
(metabolism)
- Stroke Volume
- Time Factors
- Ventricular Function, Left
- Ventricular Remodeling
|